Posted: December 3, 2009

Avisio, Inc. Forms Diagnostic Nano Applications to Commercialize Nano Sensory Technology

(Nanowerk News) Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.
Instant Detect is a portable nano-based technology that operates in the field and provides immediately-available results that do not require the expertise of a specialized lab technician to read. The technology is expected to be used by individuals in the health care and agricultural industries to detect disease-causing pathogens that can impact global food supplies and human health.
About Avisio, Inc.
Avisio, Inc. is a publicly-traded technology commercialization company with a mission to unlock the value of high-potential assets and transform them into high-value businesses. Avisio plans to create a new majority-owned private subsidiary around each asset and to support each business with experienced management teams, best-of-breed commercialization processes and resources, and access to global capital sources.
Source: Avisio (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: